RxDoctor Payments DataLook up a doctor →

Erlin Marte

Endocrinology, Diabetes & Metabolism · Buffalo, NYNPI 1316204290

Payments from drug & device makers

$570,348in general payments, 2019–2025

Across 833 payments — averaging $684.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$334K
  • Novo Nordisk$120K
  • Sanofi-aventis U.S. LLC$88K
  • Sanofi$19K
  • Boehringer Ingelheim$7K
  • Amgen$402
  • plus $1K from 12 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$570,348 in reported general payments places this provider in the 95th percentile of 804 endocrinology, diabetes & metabolism providers in New York.

See all endocrinology, diabetes & metabolism providers in New York

Other endocrinology, diabetes & metabolism in Buffalo

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →